SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR), a real estate investment trust focused on providing real
estate to the life science industry, today announced financial results for
the third quarter ended September 30, 2008.
-- Quarterly total revenues increased 24.6% to $80.8 million from
$64.8 million in the third quarter 2007
-- Completed delivery of the 84,000 square foot build-to-suit laboratory
and office facility at our Towne Centre Drive campus in San Diego to
our tenant, Illumina, Inc.
-- Continued delivery of space to Beth Israel Deaconess Medical Center,
Inc. at the Center for Life Science | Boston, bringing total occupancy
at the building to nearly 80% at the end of the quarter
-- Executed leasing transactions during the quarter representing nearly
200,000 square feet:
o Six new leases totaling approximately 52,000 square feet, including
an approximately 28,000 square foot lease with Nteryx, Inc. at our
Ardenwood Boulevard property in the Fremont/Newark submarket of the
San Francisco Bay Area
o Seven leases amended to extend their terms totaling approximately
147,000 square feet, including a 15-year extension on approximately
91,000 square feet leased to Regeneron Pharmaceuticals, Inc.,
expanding Regeneron's long-term commitment at our Landmark at
Eastview property in New York to over 348,000 square feet
-- Funds from operations (FFO) for the quarter increased 15.5% from the
third quarter 2007 to $35.6 million, or $0.48 per diluted share
"Our continued successe
|SOURCE BioMed Realty Trust, Inc.|
Copyright©2008 PR Newswire.
All rights reserved